Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cumberland Pharmaceuticals

Clinical trials sponsored by Cumberland Pharmaceuticals, explained in plain language.

Cumberland Pharmaceuticals CPIX NASDAQ

A specialty pharmaceutical company focused on hospital and gastroenterology products.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New pill could slow deadly lung scarring – early trial underway

Disease control Recruiting now

This Phase 2 trial tests whether an oral drug called ifetroban can slow the decline in lung function for people with idiopathic pulmonary fibrosis (IPF), a progressive lung-scarring disease. About 128 adults aged 40 and older with IPF will receive either ifetroban or a placebo da…

Phase: PHASE2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC